Trial Profile
Observation study for Japanese patients with head and neck cancer by combination therapy with cetuximab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2019
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Antineoplastics
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 29 Nov 2019 Status changed from active, no longer recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
- 22 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 02 Jul 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.